Status:

COMPLETED

Effect of Hyperglycemia in PAI-1 Activity and the Relationship With Outcome in Severe Sepsis and Septic Shock

Lead Sponsor:

Policlinico Hospital

Collaborating Sponsors:

Eli Lilly and Company

Conditions:

Severe Sepsis

Septic Shock

Eligibility:

All Genders

16+ years

Phase:

PHASE2

PHASE3

Brief Summary

The purpose of this study is to determine the effect of the intensive insulin therapy on coagulation and fibrinolysis in patients affected by severe sepsis and septic shock. As a secondary endpoints t...

Detailed Description

BACKGROUND The treatment of the sepsis can be done at three different level: 1. Etiologic therapy. The eradication of the infectious agent is the primary end-point. An appropriate surgical treatment...

Eligibility Criteria

Inclusion

  • Patients with sepsis, severe sepsis and sepsis shock defined as follows:
  • Sepsis:
  • Systemic response to infection with two or more of the following conditions:
  • Body temperature\<36° or \>38°
  • Heart rate \>90 bpm
  • Respiratory rate \>20 bpm or PaCO2\<32 torr
  • White cells count\>12000 mm3 or \<4000 mm3 or a differential count showing\>10% of immature neutrophiles
  • Severe sepsis:
  • Sepsis associated to a organ dysfunction.
  • Sepsis shock:
  • Sepsis associated to hypotension despite adequate fluid resuscitation, with hypoperfusion including lactic acidosis, oliguria and acute alteration of consciousness. The hypotension does not need to be present in patients treated with inotropic or vasoactive drugs.

Exclusion

  • Age below 16 years
  • Patients with hematologic malignancy or bone marrow transplant
  • Patients with type I diabetes
  • Patients with expected early death because of underlying disease.

Key Trial Info

Start Date :

November 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2007

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT00159952

Start Date

November 1 2004

End Date

November 1 2007

Last Update

November 27 2013

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Hospital "S.Paolo"

Milan, Italy

2

Policlinico Hospital

Milan, Italy

3

Hospital "S.Gerardo"

Monza, Italy

Effect of Hyperglycemia in PAI-1 Activity and the Relationship With Outcome in Severe Sepsis and Septic Shock | DecenTrialz